Schizoaffective Disorder News and Research

RSS

UM researchers develop novel, family-focused, culturally-informed treatment for schizophrenia

Researchers at the University of Miami have developed a family-focused, culturally-informed treatment for schizophrenia (CIT-S). The program is one of the first to incorporate elements of the patient's cultural background as part of therapy.

11 Nov 2014

Accumulated environmental risks have substantial impact on schizophrenia

Accumulation of environmental risk factors has a “huge” effect on age at schizophrenia onset, German researchers report.

31 Oct 2014

People with severe mental illness use YouTube to provide, receive peer support

People with severe mental illness such as schizophrenia, schizoaffective disorder or bipolar disorder use a popular social media website like YouTube to provide and receive naturally occurring peer support, Dartmouth researchers report in the journal PLOS ONE.

20 Oct 2014

Longer looks: A new kind of abortion war; foster kids and psychotropic drugs

While pro-life activists fight to rescue IVF embryos from the freezer, pregnant women in their third trimester with catastrophic fetal anomalies have nowhere to turn. ... Perhaps there is no other issue that touches on so many core dimensions of American society-;legal, medical, scientific, theological, political, philosophical, biological, ethical, and ecological. What some on one side of the debate call reproductive justice, others call taking a life. What some call a person, others call a cluster of cells.

28 Aug 2014

Impaired emotion recognition runs in families with psychosis

Difficulty recognising facial emotions is common to patients with psychosis and their close relatives, shows research.

24 Jul 2014

Johnson & Johnson sales increase 9.1% to $19.5 billion in second quarter 2014

Johnson & Johnson today announced sales of $19.5 billion for the second quarter of 2014, an increase of 9.1% as compared to the second quarter of 2013. Operational results increased 9.4% and the negative impact of currency was 0.3%.

15 Jul 2014

Maternal inflammatory marker linked to children’s schizophrenia risk

The children of women who have elevated levels of the inflammatory marker C-reactive protein during pregnancy have an increased risk of developing schizophrenia, research suggests.

3 Jul 2014

Brain structure linked to psychosis symptoms

A study of patients across the psychosis spectrum supports an association between brain structure and psychosis symptoms.

11 Jun 2014

EC approves extension of INVEGA antipsychotic drug to include adolescents aged 15 years and older

Janssen-Cilag International NV announced today that the European Commission has approved an extension of the oral atypical antipsychotic INVEGA® (paliperidone ER) schizophrenia indication, to include adolescents aged 15 years and older.

4 Jun 2014

Little efficacy difference between old and new antipsychotics

Older and second-generation long-acting antipsychotics have broadly similar clinical efficacy, shows a randomised trial in JAMA.

21 May 2014

Hippocampal role in psychosis bolstered

Reduced hippocampal volumes exist in patients across the psychosis spectrum, shows the latest report from the B-SNIP study.

21 May 2014

Reduced rheumatoid arthritis risk in schizophrenia linked to underreporting

People with a history of schizophrenia appear to have a lower risk of developing rheumatoid arthritis than the general population, but the association may be due to underreporting, say researchers.

16 Apr 2014

Further support for hippocampal volume as psychosis biomarker

Findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes provide further evidence that reduced hippocampal volume is a consistent feature of schizophrenia.

27 Feb 2014

Substance abuse worsens course of first-episode psychosis

Patients with first-episode psychosis who also present with substance abuse have a higher rate of hospitalisation after 12 months than their peers who do not, an Italian study reports.

25 Feb 2014

Factors predicting disengagement from psychosis early intervention identified

A study of first-episode psychosis patients in Hong Kong has found that those with fewer negative symptoms at presentation and poor medication compliance were more likely than others to disengage from an early intervention program.

21 Feb 2014

‘Healthy living’ programme fails to lower BMI in overweight psychosis patients

A “healthy living” intervention focused on exercise and diet has failed to impact body mass index in overweight people with psychosis when evaluated in the setting of a randomised controlled trial.

14 Feb 2014

Jazz Pharmaceuticals' Versacloz now commercially available in the U.S. for schizophrenia

Jazz Pharmaceuticals plc today announced U.S. commercial availability of Versacloz (clozapine, USP) oral suspension, the first and only oral suspension clozapine for severely ill treatment-resistant schizophrenia patients or those at risk of recurrent suicidal behavior with schizophrenia or schizoaffective disorder.

11 Feb 2014

Cognitive therapy promising for patients who shun antipsychotics

Cognitive behavioural therapy is a promising option for patients with schizophrenia who refuse to take antipsychotics, show the findings of a pilot randomised trial.

6 Feb 2014

Substance use ‘dramatically’ high in severe psychosis

Patients with severe psychotic disorders have a risk for smoking, heavy alcohol use, and other drug use that “far exceeds” that documented in patients with mild mental illness, shows a large study.

7 Jan 2014

People with severe mental illness may have higher risk for substance use

People with severe mental illness such as schizophrenia or bipolar disorder have a higher risk for substance use, especially cigarette smoking, and protective factors usually associated with lower rates of substance use do not exist in severe mental illness, according to a new study funded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health.

5 Jan 2014